A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab

被引：5
|
作者：
Schutgens, Roger E. G. [1 ]
Pruissen-Peeters, Kim A. B. M. [2 ]
Muus, Petra [3 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hematol Van Creveldklin, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Dermatol Allergol, NL-3584 CX Utrecht, Netherlands
[3] Univ Nijmegen Hosp, Dept Hematol, Nijmegen, Netherlands
来源：
THROMBOSIS AND HAEMOSTASIS | 2011年 / 106卷 / 02期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; PLASMINOGEN-ACTIVATOR RECEPTOR; NATURAL-HISTORY; THROMBOSIS; PLATELETS; PNH; INFECTION;
D O I：
10.1160/TH11-03-0165
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：383 / 385
页数：3
相关论文
共 50 条
  • [41] Successful pregnancy outcome in a patient with paroxysmal nocturnal haemoglobinuria
    Shittu, S. A.
    Hamilton, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 20 - 21
  • [42] Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria
    Iki, Seiko
    Ohgi, Kazuyuki
    Suzuki, Kenshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (03) : 231 - 232
  • [43] SAFETY AND EARLY EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB (EC) IN A CHILDHOOD PATIENT WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH)
    La Barba, G.
    Sau, A.
    Pulini, S.
    Salutari, P.
    Spadano, A.
    Fioritoni, F.
    Risitano, A. M.
    Fioritoni, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 520 - 520
  • [44] Cardiopulmonary bypass surgery in a patient with paroxysmal nocturnal haemoglobinuria
    Dinesh, D
    Baker, B
    Carter, JM
    TRANSFUSION MEDICINE, 2006, 16 (03) : 206 - 208
  • [45] Eculizumab in paroxysmal nocturnal haemoglobinuria (PNH): a report of all 153 patients treated in the UK
    Hill, A.
    Kelly, R.
    Kulasekararaj, A.
    Gandhi, S.
    Mitchell, L.
    Elebute, M.
    Richards, S.
    Cullen, M.
    Arnold, L.
    Large, J.
    Wood, A.
    Downing, T.
    McKinley, C.
    Brooksbank, G.
    Cohen, D.
    Gregory, W.
    Marsh, J.
    Mufti, G.
    Hillmen, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 3 - 4
  • [46] A CASE OF CHILDHOOD PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA: SAFETY AND EFFICACY OF THE TERMINAL COMPLEMENT INHIBITOR ECULIZUMAB
    La Barba, G.
    Sau, A.
    Pulini, S.
    Passeri, C.
    Salutari, P.
    Melatti, G.
    Risitano, A. M.
    Fioritoni, G.
    HAEMATOLOGICA, 2008, 93 : S60 - S60
  • [47] Not Happily Ever After: Complications of chronic haemolysis in paroxysmal nocturnal haemoglobinuria patients on eculizumab
    Hsu, C. H. -W.
    Proven, M.
    Eglinton, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 202 - 203
  • [48] 20 years' experience of eculizumab and ravulizumab therapy in 509 patients with paroxysmal nocturnal haemoglobinuria
    Holt, Matthew
    Kelly, Richard J.
    Vidler, Jennifer
    Arnold, Louise
    Large, Joanna
    Forrest, Briony
    Barnfield, Catherine
    Pike, Alexandra
    Griffin, Morag
    Munir, Talha
    Muus, Petra
    Nagumantry, Sateesh
    Trikha, Roochi
    Kulasekararaj, Austin
    Mitchell, Lindsay
    Gandhi, Shreyans
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 22 - 22
  • [49] Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry
    Almeida, Antonio M.
    Bedrosian, Camille
    Cole, Alexander
    Muus, Petra
    Schrezenmeier, Hubert
    Szer, Jeff
    Rosse, Wendell F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (09) : 1026 - 1034
  • [50] LONG-TERM EVOLUTION OF TYPE III ERYTHROCYTES DURING ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
    Moncharmont, P.
    Barraco, F.
    Bernaud, J.
    Raffin, A.
    Michallet, M.
    Rigal, D.
    HAEMATOLOGICA, 2012, 97 : 574 - 575
12345